SEC Form 4 · accession 0001127602-15-033389
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred Sandrock
Officer — EVP CMO Neuro & Neurodegenerat
Period of report
Dec 3, 2015
Accepted (ET)
Dec 7, 2015 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 3, 2015 | F | 393 | $275.44 | D | 8,181 | D | |
| Common Stock | Dec 4, 2015 | S | 441 | $277.00 | D | 7,740 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.